The global sleep apnea implants market is expected to grow from USD 317.1 million in 2023 to USD 1,158.1 million by 2033, at ...

Awareness of sleep apnea and its relatively common and effective treatment has grown over the past three decades.

The U.S. Food and Drug Administration (FDA) has approved the first prescription medication specifically for treating obstructive sleep apnea (OSA): the weight-loss drug Zepbound. Packed holiday ...

Tirzepatide is the active ingredient in Zepbound, the FDA approved prescription medicine for Obstructive Sleep Apnea.

Sleep apnea affects 25 million Americans and 100 million individuals worldwide. Prior to the approval of Zepbound, those affected have mainly been offered a CPAP machine for treatment, often ...

The cycle may be repeated throughout sleep. Because OSA and CSA have different primary causes, optimal therapy may differ for these 2 distinct disorders. However, for patients with CHF, a paucity of ...

Transcranial Electrical Stimulation (tES) is a promising non-invasive brain modulation tool. Over the past years, there have been several attempts to modulate sleep with tES-based approaches in both ...

Continuous positive airway pressure (CPAP)—which uses a machine that pushes pressure into your airways to prevent their inward collapse—is the primary treatment for obstructive sleep apnea (OSA).

As Zepbound becomes available for this new indication, its role in addressing the interconnected challenges of obesity and sleep apnea may redefine treatment strategies for millions struggling ...

Nyxoah's Genio implant is poised to revolutionize Obstructive Sleep Apnea treatment, with FDA approval ... a 6cm incision in the chin to introduce a stimulator, which is controlled by an external ...

“For some patients who have sleep apnea, combining another treatment with Zepbound may be ideal,” the association says. “Furthermore, weight loss from Zepbound must be maintained over time to continue ...

The FDA approved Zepbound (tirzepatide) as the first prescription medication specifically for adults with moderate-to-severe obstructive sleep apnea (OSA) and obesity. People taking Zepbound lost ...